Established in 1943, Shandong Xinhua Pharmaceutical Company Limited (Shandong Xinhua) is dedicated in the research and development, manufacturing and distributing high quality pharmaceutical products. As one of the key pharmaceutical companies in China, Shandong Xinhua is in a leading position in the manufacturing technology and capacity for antipyretics and analgesics in Asia and is an important manufacturer in China for the drugs of central nervous system, anti-infection and cardiovascular and cerebrovascular diseases system, oncology and anti-parasites. As a public company of H shares in Hong Kong and A shares in Shenzhen, good company governance system has been established in Shandong Xinhua, and brand of Shandong Xinhua is honored with the title of “Chinese Famous Brand” and a brand recognized by the Ministry of Commerce of China for high quality exporting products. With the commitment for high-quality products, Shandong Xinhua has been granted the certifications of GMP, ISO9001, ISO14001, ISO 10012, and the API products granted the COS Certificates from EU EDQM and passed the site inspection from USA FDA, and solid dosage plant was approved for EU cGMP by UK MHRA. And the R&D Institute of Shandong Xinhua is one of the first National Centers for Enterprise Technology Development and Postdoctoral Workstation, and the prominent advantages has been established in APIs, dosage forms and fine chemical’s research and development with 120 authorized patents in the house. For the sustained and long-term development, Shandong Xinhua will strengthen the commitment in the innovative product’s development and good service to the overseas clients with the commitment to create the name of Shandong Xinhua with global reputation. High quality products and good services is always Shandong Xinhua’s solid base to follow our mission of “For Better Life and Good Society”.
Tel: 0086-533-2196810 Fax: 0086-533-2196901